Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Financing Cash Flow
$4.47M
Quarterly · Period ending: · USD
LCTX Financing Cash Flow
Latest reported$4.47Mperiod ending
Latest reported$4.47Mperiod ending
LCTX Quarterly Cash from Financing (-$200.00K → $4.47M)
Quarterly financing cash flow
High-resolution chart · PNG
LCTX financing cash flow history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 4,466,000 | |
| 5,561,000 | |
| 20,379,000 | |
| 1,834,000 | |
| -307,000 | |
| 5,044,000 | |
| 21,734,000 | |
| -3,000 | |
| 105,000 | |
| 14,021,000 | |
| -13,000 | |
| 807,000 | |
| 5,628,000 | |
| 1,000 | |
| 122,000 | |
| 964,000 | |
| 33,000 | |
| 513,000 | |
| 954,000 | |
| 3,719,000 | |
| 11,294,000 | |
| 20,963,000 | |
| 4,814,000 | |
| 24,558,000 | |
| 503,000 | |
| -10,000 | |
| -5,000 | |
| 79,000 | |
| -63,000 | |
| 606,000 | |
| 94,000 | |
| 145,000 | |
| 4,902,000 | |
| 633,000 | |
| 26,379,000 | |
| 4,992,000 | |
| 4,923,000 | |
| 19,097,000 | |
| 843,000 | |
| 12,208,000 | |
| 18,967,000 | |
| 764,000 | |
| 29,544,000 | |
| 11,159,000 | |
| 18,388,142 | |
| 5,683,858 | |
| 30,973,206 | |
| 458,344 | |
| 20,063,208 | |
| 12,128,485 | |
| 9,126,257 | |
| -165 | |
| 12,024,378 | |
| 13,113,138 | |
| 1,626,826 | |
| 271,752 | |
| 14,800 | |
| 0 | |
| 733 | |
| 3,034,300 | |
| 137,550 | |
| 689,831 | |
| 7,094,264 | |
| 9,631,789 | |
| 8,585,115 | |
| 456,288 | |
| 5,097,702 | |
| 4,733,339 | |
| 5,090,023 | |
| 1,561,902 | |
| 580,363 | |
| 748,701 | |
| 618,223 | |
| 569,608 | |
| 354,937 | |
| 40,000 | |
| 200,000 | |
| 100,000 | |
| -126 | |
| 0 | |
| 0 | |
| 126 | |
| 1,309,332 | |
| 247,828 | |
| 320,000 | |
| 0 | |
| -4,184,420 | |
| 0 | |
| 18,307 | |
| 2,171,967 | |
| 0 | |
| 0 | |
| 86,896 | |
| 0 | |
| -28,076 | |
| 1,792,746 | |
| 0 | |
| 0 | |
| -12 | |
| 2,850,000 |